Albemarle's Best Quarter in Years Meets a 28% Drawdown
A $646 million EBITDA print, a raised Specialties guide, and a stock down 31% from its August peak — inside the lithium market's broken price signal.
ALB · Earnings Call · 2026-11-05
A quarter the tape refuses to believe
Albemarle's third quarter was, on the page, the best operating print in years. Net sales of $1.6 billion rose 19% year over year; adjusted EBITDA of $646 million jumped 186%; margins expanded to 42%. The company generated $1.5 billion of operating cash flow year-to-date and $1.2 billion of free cash flow, a 67% conversion rate at the top of its own benchmark. It raised its Specialties EBITDA outlook to $350–375 million and cut 2026 capital spending to $300–350 million from roughly $500 million. And yet the stock is down 27.7% over the last 90 days, 31.3% below its August 21 peak. That is the tension at the heart of this call: a company executing better than it has in years, into a market that is pricing its product as if the cycle is rolling over.
The disconnect is now the story
The freshest theme in the transcript is not demand — it is the gap between what Albemarle sees in the physical lithium market and what the futures market is saying. Kent Masters put it plainly: “It's a little kind of see what you see in the trading markets is a little disconnected from the physical market.” — Jerry Masters, Chief Executive Officer · 2026-11-05 Eric Norris went further.
Bottom line, you'll never hear us get out and try to predict price ourselves, but the fundamentals in the physical market don't support what we're seeing in the spot market now.
That is a new emphasis. The keyword physical market surfaces near the top of this company's keyword trajectory for the first time. The demand data management cites is genuinely striking: global lithium consumption up 48% year-to-date, stationary storage production nearly doubled, roughly 1,000 gigawatt-hours of storage projects in the 2027 pipeline, EV sales up 11% with Europe +35% and the rest of the world +94%. Inventories are described as healthy, not bloated. Yet spot prices are falling. This is not entirely new rhetoric. In August, Masters called lithium “a very speculative market, driven by traders in China for the most part.” — Jerry Masters, CEO (Kent Masters; speaker is Kent Masters, misattributed as Jerry Masters) · 2026-08-06 But the intensity has changed. This quarter, management is effectively arguing the market is wrong.
Capex, cost, and the buyback that isn't
What management did with the cash is as telling as what it said about the market. Capital spending has been demolished over three years — the last filed quarter showed capex of just $72 million, down 40% year over year and 80% below the 2024 peak. Capital expenditure fell to $72 million in the latest filed quarter, versus a $580 million peak in early 2024. The 2026 guide was cut again, to $300–350 million, with sustaining capital targeted below $300 million. Neal Sheorey: “you should expect our CapEx will go up but go up modestly next year, so not a spike in CapEx.” — Neal Sheorey, Chief Financial Officer · 2026-11-05Cost savings are also decelerating. The company hit $150 million of run-rate cost and productivity improvements year-to-date — the high end of its full-year target. But compare that to the prior cycle: in July 2025, management was touting a $400 million run rate achieved six months early, with line of sight to $450 million. “Not only are we at the high end of our range, but we're hitting that run rate 6 months early.” — Neal R. Sheorey, Chief Financial Officer · 2025-07-31 The easy savings are gone.Then there is the buyback question, which Joel Jackson asked directly. Masters acknowledged the balance sheet is strong — effective net cash improved by about $1.8 billion over the last three quarters, to a net debt position of $320 million. — but he deferred: “if the timing is not right, we will look at buybacks.” — Jerry Masters, Chief Executive Officer · 2026-11-05 The message is that management would rather wait for the cycle to clarify than buy its own stock at a 31% drawdown. That is either discipline or a lack of conviction, depending on your view.
Supply skepticism and the 2027 setup
The most consequential new theme is supply. Management spent unusual time casting doubt on the marginal supply that the market is pricing in. The supply growth story is weaker than headlines suggest: Zimbabwe's export ban has been reaffirmed, African logistics are challenged, Australian spodumene announced at higher prices is uneconomic at current levels, and the CATL lepidolite mine — about 3% of 2026 supply — remains opaque on permitting. Masters: "there are probably more questions in our mind on downside to supply than our upside for '27." That is a direct challenge to the bears. If management is right, 2027 is tighter than the futures curve implies. If the market is right, 2027 loosens and Albemarle's volume growth from CGP3 and Wodgina runs into a soft price.The company also flagged a Q4 step-down: Energy Storage revenue and EBITDA are expected to decline sequentially as higher-priced Talison spodumene flows through inventory into COGS while pricing falls. That spodumene lag is a recurring theme — Neal noted in August that it takes about four months for spodumene to move through the system. It is the third consecutive quarter where the lag has distorted margins.One useful contrast: the global tape has punished anything touching AI data centers, down sharply across the semiconductor and power complex. Albemarle is not that trade. Eric Norris noted U.S. grid storage installations are only about 7% of the global market and data-center-driven demand is a small piece of the story. The stock fell anyway — because lithium price, not AI, is the driver.
The bottom line
Albemarle delivered a genuinely strong quarter and told investors the market is mispricing its product. The stock is voting the other way. The capex cut, the strong balance sheet, and the buyback option are the hedges if management is wrong about the timing. The new CEO, Rag Udd, inherits the argument. For now, the market is treating the physical-market tightness as a lagging indicator and the futures curve as the truth. That is the bet investors are making — and the one management is asking them to reconsider.